Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Takotsubo Syndrome Presenting as Cardiogenic Shock in Patients With COVID-19: A Case Series and Review of Current Literature.

Tytuł:
Takotsubo Syndrome Presenting as Cardiogenic Shock in Patients With COVID-19: A Case Series and Review of Current Literature.
Autorzy:
Kong N; Department of Internal Medicine, University of Chicago, Chicago, IL, United States of America.
Singh N; Department of Internal Medicine, Section of Cardiology, University of Chicago, Chicago, IL, United States of America.
Mazzone S; Department of Internal Medicine, Section of Cardiology, University of Chicago, Chicago, IL, United States of America.
Burkhart R; Department of Internal Medicine, Section of Cardiology, University of Chicago, Chicago, IL, United States of America.
Anchan R; Department of Internal Medicine, Section of Cardiology, University of Chicago, Chicago, IL, United States of America.
Blair J; Department of Internal Medicine, Section of Cardiology, University of Chicago, Chicago, IL, United States of America. Electronic address: .
Źródło:
Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2021 Jul; Vol. 28S, pp. 50-53. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji:
Case Reports
Język:
English
Imprint Name(s):
Original Publication: New York, NY : Elsevier, c2005-
MeSH Terms:
COVID-19*
Heart Failure*
Takotsubo Cardiomyopathy*/diagnosis
Takotsubo Cardiomyopathy*/therapy
Humans ; SARS-CoV-2 ; Shock, Cardiogenic/diagnosis ; Shock, Cardiogenic/etiology ; Shock, Cardiogenic/therapy
Grant Information:
T32 HL007381 United States HL NHLBI NIH HHS
Contributed Indexing:
Keywords: COVID-19; Cardiogenic shock; Cardiomyopathy; Takotsubo
Entry Date(s):
Date Created: 20210131 Date Completed: 20210825 Latest Revision: 20220201
Update Code:
20240104
DOI:
10.1016/j.carrev.2021.01.017
PMID:
33516638
Raport
Takotsubo's syndrome (TTS) is a form of stress cardiomyopathy with a relatively benign long-term course, but may lead to arrhythmias and cardiogenic shock in the acute setting. Despite a recent rise in suspected stress-induced cardiomyopathy, the relationship between the novel coronavirus disease 19 (COVID-19) and TTS is not fully understood. Early recognition of TTS in these patients is important to guide management and treatment. We present 2 cases of TTS arising in the setting of COVID-19 with rapid progression to biventricular heart failure and cardiogenic shock.
Competing Interests: Declaration of Competing Interest The authors have no relevant financial or industry disclosures.
(Copyright © 2021 Elsevier Inc. All rights reserved.)
Comment in: Cardiovasc Revasc Med. 2022 Jan;34:148-149. (PMID: 33674217)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies